DEA warns Georgia pharmacies to halt low-THC medical marijuana oil sales - MJBizDaily
DEA orders Georgia pharmacies to stop dispensing low-THC medical marijuana oil, citing federal law violations.
Aforeworn detected this change in the Pharmacy & Controlled Substances space on July 28, 2026 and published this briefing so affected operators are forewarned rather than caught off guard. It is rated Critical. Georgia pharmacies (independent, retail chains, compounding, long-term-care) dispensing low-THC oil under state's medical program. should confirm how it applies to their specific situation before acting. There is a time constraint attached: Immediate. Acting after that point can mean penalties, a lapsed licence, or lost eligibility — exactly the kind of surprise Aforeworn exists to prevent. Aforeworn monitors Pharmacy & Controlled Substances continuously and turns every detected change into a plain-English briefing like this one, so you always know first. Forewarned is forearmed.
What changed
DEA issued warning that dispensing low-THC medical marijuana oil violates federal Controlled Substances Act; pharmacies must cease immediately.
Who it affects
Georgia pharmacies (independent, retail chains, compounding, long-term-care) dispensing low-THC oil under state's medical program.
What you must do
Immediately halt all dispensing of low-THC medical marijuana oil and review compliance with federal law.
Deadline
Immediate
Never miss a change like this again
Aforeworn watches Pharmacy & Controlled Substances around the clock and alerts you the moment a rule moves — with a plain-English brief on what to do.
Start your free trialRelated changes in Pharmacy & Controlled Substances
- Pharmacy technicians must register with Florida's Board of Pharmacy by Jan. 1, 2010 - Drug Topics
- Judge Trims DEA's Suspension Of Fla. Pharmacy's Permits - Law360
- New Wisconsin Law Regulates PBM and Other Stakeholders Involved in Drug Pricing - Quarles
- Pharmacists in WV can now give COVID-19 vaccines without prescriptions - Charleston Gazette-Mail
- What Does DEA’s Proposed Special Registration Framework for Tele-prescribing Controlled Substances Mean? - Reed Smith LLP